CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 78 enrolled
Drug / intervention
iTransitionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04383223
NCT04383223N/ACompleted
CompareCT.gov

iTransition: Pilot Testing a Multilevel Technology Based Intervention to Support Youth Living With HIV From Adolescent to Adult Care

Emory University·interventional·Posted May 12, 2020·Updated Aug 13, 2025

In Brief

A clinical study evaluating iTransition for Human Immunodeficiency Virus and HIV Seropositivity. Completed, enrolled 78 participants across 3 sites.

Detailed Summary

Youth living with HIV are at high risk of falling out of care when they transition from pediatric to adult care. The investigators are proposing to develop a mobile app to help both clinical providers and patients navigate this process.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHuman Immunodeficiency Virus, HIV Seropositivity
CountriesUnited States
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedMay 12, 2020
Enrollment StartAug 28, 2020
Primary CompletionJun 30, 2024
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 6.1 years ago

Interventions

iTransitionbehavioral

Is a mobile website application (app), and it can be used on a range of devices (computer, tablet, smartphone) and operating systems (iOS, Android, Windows). Features of iTransition will include, but are not limited to: medication reminders, calendar tracking of appointments, direct messaging between youth and providers, and privacy password lock.